The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy
Open accessAbstract
BACKGROUND: Sepsis is a global healthcare problem, characterized by whole body inflammation in response to microbial infection, which leads to organ dysfunction. It is becoming a frequent complication in hospitalized patients. Early and differential diagnosis of sepsis is needed critically to avoid unnecessary usage of antimicrobial agents and for proper antibiotic treatments through the screening of biomarkers that sustains with diagnostic significance. MAIN BODY OF ABSTRACT: Current targeting conventional markers (C-reactive protein, white blood cell, tumour necrosis factor-α, interleukins, etc.) are non-specific for diagnosing sepsis. Procalcitonin (PCT), a member of the calcitonin super family could be a critical tool for the diagnosis of sepsis. But to distinguish between bacterial versus viral infections, procalcitonin alone may not be effective. Rapid elevation in the concentration of procalcitonin and other newly emerging biomarkers during an infection and its correlation with severity of illness makes it an ideal biomarker for bacterial infection. Beside this, the procalcitonin levels can be used for monitoring response to antimicrobial therapy, diagnosis of secondary inflammations, diagnosis of renal involvement in paediatric urinary tract infection, etc. The present article summarizes the relevance of procalcitonin in the diagnosis of sepsis and how it can be useful in determining the therapeutic approaches. CONCLUSION: Further studies are needed to better understand the application of PCT in the diagnosis of sepsis, differentiating between microbial and non-microbial infection cases and determining the therapeutic approaches for sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“There-fore, procalcitonin is currently in clinical use as a biomarker for assessing risk of sepsis and septic shock (208).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [208]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Severe Sepsis and Septic Shock
Angus, D. C., & van der Poll, T. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208623 · Cited by 3,961
High serum procalcitonin concentrations in patients with sepsis and infection
Assicot, M., Bohuon, C., Gendrel, D., Raymond, J., Carsin, H., & Guilbaud, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90277-n · Cited by 2,197
Feldmann, H., & Geisbert, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)60667-8 · Cited by 1,374
Procalcitonin as a diagnostic marker for sepsis: A systematic review and meta-analysis.
Wacker, C., Prkno, A., Brunkhorst, F. M., & Schlattmann, P. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70323-7 · Cited by 1,198
Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit
Müller, B., Becker, K. L., Schächinger, H., Rickenbacher, P. R., Huber, P. R., Zimmerli, W., & Ritz, R. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004000-00011 · Cited by 628
Use of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients
Nobre, V., Harbarth, S., Graf, J.-D., Rohner, P., & Pugin, J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1238oc · Cited by 605
The inflammatory response in sepsis
Bosmann, M., & Ward, P. A. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.09.004 · Cited by 558
New Approaches to Sepsis: Molecular Diagnostics and Biomarkers
Reinhart, K., Bauer, M., Riedemann, N. C., & Hartog, C. S. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-12 · Cited by 533
Role of cytokines as a double-edged sword in sepsis.
Chaudhry, H. R., Zhou, J., Yin, Z., Ali, M. M., McGuire, F. R., Nagarkatti, P. S., & Nagarkatti, M. (2013) · PubMed · Cited by 526
Research works printed but not linked: 2
- Willey J, Sherwood L, Christopher JW. Prescotts’s Microbiol, International edition. 8th ed; 2011. p. 97.
- Katherine S, Roma LH. Proclacitonin: an emerging biomarker of bacterial sepsis. Clin Microbiol Newsletter. 2001;3:171–8.
Cited by
The Pathogenesis of Sepsis and Potential Therapeutic Targets
Huang, M., Cai, S., & Su, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215376 · Cited by 776
Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysis
Tian, W., Jiang, W., Yao, J., Nicholson, C. J., Li, R. H., Sigurslid, H. H., Wooster, L., Rotter, J. I., Guo, X., & Malhotra, R. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26050 · Cited by 640
The Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
Full-length single-molecule protein fingerprinting
Filius, M., van Wee, R., de Lannoy, C., Westerlaken, I., Li, Z., Kim, S. H., de Agrela Pinto, C., Wu, Y., Boons, G.-J., Pabst, M., et al. (2024) · Nature Nanotechnology · doi:10.1038/s41565-023-01598-7 · Cited by 30
Full-Length Single-Molecule Protein Fingerprinting
Filius, M., van Wee, R., de Lannoy, C., Westerlaken, I., Li, Z., Kim, S. H., de Agrela Pinto, C., Wu, Y., Boons, G.-J., Pabst, M., et al. (2023) · doi:10.1101/2023.09.26.559471 · Cited by 2
Metadata
- Authors
- Vijayan, A. L., Vanimaya, Ravindran, S., Saikant, R., Lakshmi, S., Kartik, R., & G, M.
- Affiliations
- HLL Lifecare (India) (IN)
- Venue
- Journal of Intensive Care
- Published
- 2017-08-03
- Volume
- 5
- Issue
- 1
- Pages
- 51-51
- ISSN
- 2052-0492 (ISSN-L)
- PMC
- PMC5543591
- OpenAlex
- W2744780151
- Cited by
- 477
- References
- 57
- Citations by year
- 2026: 37 · 2025: 47 · 2024: 69 · 2023: 72 · 2022: 79 · 2021: 70 · 2020: 59 · 2019: 29 · 2018: 13 · 2017: 2
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Intensive Care (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- procalcitonin, sepsis, sepsis diagnosis, biomarkers, antibiotic stewardship, bacterial infection, C-reactive protein, inflammatory cytokines, pediatric urinary tract infection, secondary inflammation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. https://app.cochat.ai/papers/10.1186/s40560-017-0246-8
- The paper
- Vijayan, A. L., Vanimaya, Ravindran, S., Saikant, R., Lakshmi, S., Kartik, R., & G, M. (2017). Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. Journal of Intensive Care. https://doi.org/10.1186/s40560-017-0246-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

